March 3, 2020 |
Turning scientific knowledge and data into evidence


March 3, 2020 – London, UK, Parsippany and Bethesda, USA – Meet two of OPEN Health’s practices—Peloton Advantage and Pharmerit International—at booth #4 at MAPS Global 2020, the World’s Largest Assembly of Medical Affairs Professionals, to be held in Miami, Florida from March 8 – 11, 2020.
Peloton Advantage along with OPEN Health Medical Communications provides expertise in Medical Affairs content and consultancy, publication planning and management, medical education, and internal training. By joining OPEN Health in late 2019, Pharmerit deepens OPEN Health’s strategic and scientific capabilities in health economics and outcomes research (HEOR) and market access and expands Pharmerit’s ability to communicate with the broader scientific community. For more information on the two practices, please visit our website.
OPEN Health practices are supported by creative and digital teams to translate scientific concepts and communications into compelling visuals and deliver innovation with measurable results, all while ensuring data security and compliance. Together, the OPEN Health family is a full-service, trusted, innovative partner for Medical Affairs.
Contact:
OPEN Health: Sandy Royden
sandyroyden@openhealthgroup.com
+44 1628 481112
Peloton Advantage: Carolyn Clark
cclark@pelotonadvantage.com
+1 973 582 5701
Pharmerit International: Candice Subero
+1 240 483 4323
About OPEN Health Communications, LLP:
OPEN Health is a global multidisciplinary health communications and market access group, operating within three core business areas: Medical Communications; Patient and Brand Communications; and HEOR / Access and Evidence. OPEN Health was formed in 2011, and whilst working across a broad therapeutic range has a strong focus on oncology, rare diseases, and specialist medicines.
For further information on OPEN Health, please visit www.openhealthgroup.com.
About Pharmerit International, LP:
Pharmerit International is a global, premier health economics and outcomes research (HEOR) consultancy with 20 years of experience supporting pharmaceutical, biotechnology, and medical device organizations in health economics and outcomes research (HEOR) and market access worldwide. Pharmerit delivers quality research across four multidisciplinary Centers of Excellence: Modeling & Meta-Analysis, Patient-Centred Outcomes, Real-World Evidence, and Strategic Market Access.Pharmerit has offices in Berlin, Bethesda, Boston, Mumbai, Oxford, New York, Rotterdam, York, and Shanghai.
For further information on Pharmerit International, please visit www.pharmerit.com.
About Peloton Advantage, LLC:
Peloton Advantage, LLC is a privately-owned medical communications company specializing in strategic publication planning and associated content development for medical education programs. Peloton’s teams support US and global accounts for large and small pharmaceutical, biotechnology, and medical device companies, contributing to the success of more than 90 products spanning all major therapeutic areas.
For further information on Peloton Advantage, please visit www.pelotonadvantage.com.
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
OPEN Health today announced the appointment of Tim Perryman as Global Head of Operations, strengthening the company’s operational leadership as it continues to scale its global capabilities and support clients...
OPEN Health today announced the appointment of Peter Black as EVP, Global Client Partner and Transformation Lead.
OPEN Health today announced the appointment of Cara Priest as Chief People Officer, reinforcing the company’s commitment to building a high-performing culture that supports its continued growth and scientific excellence.
OPEN Health Group is pleased to announce the appointment of Matt D’Auria as its new Chief Executive Officer (CEO). Based in the US, Matt brings more than 25 years of...
OPEN Health is pleased to announce the appointment of David Sakadelis as Chief Technology Officer. In this role, David will be responsible for enhancing our services through technology-enabled solutions for...
Discover the key takeaways from OPEN Health’s latest whitepaper: "The Potential Impact of the New Presidential Administration on the Future of the Inflation Reduction Act and Broader Healthcare Policy."
OPEN Health is excited to announce the upcoming presentation of a collection of research supported by its Scientific Buyout Program. This initiative empowers our team members to dedicate time toward...
OPEN Health, a pre-eminent global provider of scientific communications, HEOR and market access, patient engagement, and consulting, today announced a partnership with fusion, an innovative artificial intelligence (AI) and machine...
OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry
OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer
